ANAMIKA KHARB: Open Payments
NPI 1770190159 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,653 in 64 payments from 15 companies in 2025. Trend: 2023 $797 · 2024 $721 · 2025 $1,653
Food & beverage: $1,497Education: $156
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $593 |
| ABBVIE INC. | 13 | $277 |
| UCB, Inc. | 7 | $168 |
| Lilly USA, LLC | 5 | $108 |
| PFIZER INC. | 3 | $100 |
| Genentech USA, Inc. | 5 | $93 |
| Mallinckrodt Hospital Products Inc. | 2 | $69 |
| Actelion Pharmaceuticals US, Inc. | 2 | $65 |
| Amgen Inc. | 3 | $57 |
| TerSera Therapeutics LLC | 1 | $32 |
Products named: TREMFYA, RINVOQ, Bimzelx, TALTZ, XELJANZ, Actemra, SKYRIZI, ACTHAR.
Industry payments across NY — which companies pay providers there.
